Precision Biosciences (DTIL) Profit After Tax Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 9.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.72% |
| Dec 31, 2025 | 32.59% |
| Sep 30, 2025 | -11.54% |
| Jun 30, 2025 | 8.83% |
| Mar 31, 2025 | 9.96% |
| Dec 31, 2024 | 7.32% |
| Sep 30, 2024 | -13.35% |
| Jun 30, 2024 | 14.78% |
| Mar 31, 2024 | 34.98% |
| Dec 31, 2023 | 11.44% |
| Sep 30, 2023 | 22.50% |
| Jun 30, 2023 | 28.62% |
| Mar 31, 2023 | 2.26% |
| Dec 31, 2022 | -40.62% |
| Sep 30, 2022 | 8.88% |
| Jun 30, 2022 | -16.88% |
| Mar 31, 2022 | 3.94% |
| Dec 31, 2021 | -13.01% |
| Sep 30, 2021 | -4.95% |
| Jun 30, 2021 | 56.48% |
| Mar 31, 2021 | -27.52% |